data_1i8y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1i8y _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 6.4 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.918 0.39 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.09 20.89 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.68 -10.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.34 12.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 41.3 m -143.8 -50.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 54.28 80.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.391 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 72.1 m -70.53 157.23 90.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.523 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.784 ' HB2' HG22 ' A' ' 12' ' ' THR . 73.2 Cg_exo -48.68 162.2 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.518 2.145 . . . . 0.0 112.521 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.62 128.16 34.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.256 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.7 59.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.961 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.784 HG22 ' HB2' ' A' ' 9' ' ' PRO . 24.9 p -133.02 154.13 50.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.9 t -126.46 148.6 49.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.006 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.514 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.8 p -114.8 144.72 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.8 146.49 43.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.649 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.413 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 63.1 tp -78.37 137.23 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.5 156.81 38.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.22 -8.33 14.16 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.444 2.096 . . . . 0.0 112.293 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -98.43 -22.66 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.654 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.22 43.51 1.49 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.415 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.75 148.87 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.213 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.413 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 92.1 m95 -117.51 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 10.5 p90 -143.37 148.75 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -114.47 149.06 36.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.031 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 85.8 p -137.19 138.75 26.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 6.2 Cg_exo -78.75 20.41 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.02 2.48 . . . . 0.0 112.517 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -140.41 35.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.404 ' HA ' ' CG2' ' A' ' 13' ' ' THR . 3.0 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.825 0.345 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -160.67 114.64 2.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.5 42.86 26.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.87 -49.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -113.61 -61.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.6 mt 64.58 107.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.07 162.23 62.72 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.658 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.09 149.76 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.596 2.197 . . . . 0.0 112.562 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -62.86 135.61 57.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.88 9.68 85.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.645 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -126.61 150.36 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 0.0 111.242 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.1 t -120.06 152.34 37.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 p -114.72 126.61 55.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.3 147.78 42.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.808 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.03 116.26 21.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.94 156.97 86.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.693 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.91 -11.7 13.0 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.55 2.167 . . . . 0.0 112.207 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.23 -41.66 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.725 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.54 39.44 0.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.317 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 22' ' ' TRP . 12.4 p -129.55 152.54 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 0.0 111.173 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' N ' HG23 ' A' ' 21' ' ' VAL . 84.6 m95 -114.2 119.64 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 4.3 p90 -127.04 145.73 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -119.04 135.39 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.905 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.8 133.28 9.73 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.02 98.83 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.148 . . . . 0.0 112.564 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -135.66 179.99 6.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.924 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.511 0.196 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.68 32.56 18.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.16 -19.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.58 -38.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.2 m -94.38 -63.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.9 mt 64.78 124.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.571 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.95 152.0 86.52 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.93 136.85 22.8 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 61.88 -170.01 0.17 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.963 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 68.02 2.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.274 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.6 p -130.9 155.65 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -114.2 152.68 30.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.568 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -114.55 147.04 40.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.113 0.482 . . . . 0.0 111.506 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.04 148.7 30.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.347 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.43 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 46.5 tp -93.0 109.1 20.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.222 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.31 162.29 73.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -61.62 -11.1 18.83 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.369 2.046 . . . . 0.0 112.351 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -92.72 5.7 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.67 50.4 36.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.454 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.88 150.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.35 . . . . 0.0 111.314 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.43 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 87.0 m95 -117.8 122.77 44.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.582 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.2 150.37 39.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -118.94 143.84 46.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.743 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -124.46 136.63 28.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.162 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 10.3 Cg_exo -71.66 -18.85 28.53 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.902 2.401 . . . . 0.0 112.31 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 57.6 43.84 21.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.868 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 14' ' ' CYS . 69.3 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.841 0.353 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.66 178.27 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 54.4 -151.39 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.079 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.05 75.45 4.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.286 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -130.0 -72.59 0.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.073 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt 49.22 73.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.397 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 1.7 m -69.45 168.11 18.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.535 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.634 ' HB2' HG22 ' A' ' 12' ' ' THR . 90.2 Cg_exo -44.98 152.78 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.445 2.097 . . . . 0.0 112.651 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -22.67 61.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.588 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 26' ' ' PRO . . . -102.39 19.21 49.05 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.729 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.634 HG22 ' HB2' ' A' ' 9' ' ' PRO . 27.9 p -137.28 155.42 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.36 . . . . 0.0 111.093 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.566 HG21 ' HZ ' ' A' ' 27' ' ' PHE . 10.8 t -115.51 156.42 25.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.356 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 12.0 m -113.67 127.96 56.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 m -142.6 141.6 32.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.445 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 62.4 tp -98.44 108.3 20.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.71 156.6 63.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.706 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.87 -17.13 22.53 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.54 2.16 . . . . 0.0 112.39 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -83.9 -33.88 24.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.71 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.41 ' HA2' HD13 ' A' ' 16' ' ' LEU . . . 114.44 44.83 0.7 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.319 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.81 152.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.022 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.2 m95 -114.81 128.53 56.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.527 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -129.0 150.46 50.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.225 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 84.8 m -144.15 120.27 10.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.793 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 t -131.13 144.39 53.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 11' ' ' GLY . 98.3 Cg_endo -79.9 133.37 10.12 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.573 2.182 . . . . 0.0 112.304 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.566 ' HZ ' HG21 ' A' ' 13' ' ' THR . 0.3 OUTLIER -101.15 99.47 9.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.986 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.805 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 24.3 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -153.34 108.24 3.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 57.48 37.38 27.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 -26.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 99.4 m -110.05 -53.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 mt 60.67 91.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -83.31 165.68 39.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.136 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.685 ' HB2' HG23 ' A' ' 12' ' ' THR . 81.9 Cg_exo -42.07 133.4 4.4 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.449 2.1 . . . . 0.0 112.365 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -50.48 119.98 4.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.4 10.59 50.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.617 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.685 HG23 ' HB2' ' A' ' 9' ' ' PRO . 6.9 p -129.31 150.24 50.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.299 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -119.95 143.43 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.76 146.35 41.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 111.351 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.49 137.09 15.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 57.5 tp -64.39 132.72 50.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 153.43 46.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.431 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.58 -14.88 18.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.084 . . . . 0.0 112.277 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -88.62 -32.02 18.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.69 46.31 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.854 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.22 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.435 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 87.1 m95 -116.44 124.24 49.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.174 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -149.59 144.72 26.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.458 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -117.61 132.79 56.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.629 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -117.44 136.99 23.7 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.227 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.75 2.14 8.75 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.377 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 61.44 -179.06 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.164 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.87 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.538 ' HA ' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.666 0.269 . . . . 0.0 111.006 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.86 5.85 41.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.007 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.44 -71.56 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.462 ' O ' HG22 ' A' ' 6' ' ' THR . . . -135.6 -57.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.538 ' HB ' ' HA ' ' A' ' 2' ' ' CYS . 5.1 t 42.43 -159.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.973 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 pt -141.07 43.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 65.6 m -113.68 152.19 45.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.731 ' HB2' HG21 ' A' ' 12' ' ' THR . 55.1 Cg_exo -52.19 170.83 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.764 2.309 . . . . 0.0 112.788 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 118.36 12.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.4 30.18 28.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.74 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.731 HG21 ' HB2' ' A' ' 9' ' ' PRO . 63.0 p -130.45 154.69 47.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.064 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.1 t -121.08 155.41 34.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.619 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.7 p -114.22 134.92 54.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.937 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.86 147.55 31.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -84.73 138.2 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.66 158.79 32.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.73 -0.57 3.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.457 2.104 . . . . 0.0 112.649 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -104.06 -14.66 15.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.26 3.87 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.87 150.66 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 0.0 111.182 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.407 ' CE2' ' HG ' ' A' ' 16' ' ' LEU . 87.3 m95 -114.88 141.6 47.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.49 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -152.96 153.58 33.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 13' ' ' THR . 4.6 m -114.79 119.17 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.93 141.38 41.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.33 31.96 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.695 2.264 . . . . 0.0 112.834 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -161.02 40.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 111.036 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.449 ' HA ' HG22 ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.891 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.961 0.41 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.63 107.44 16.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.184 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 50.66 -98.99 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.534 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.55 50.61 0.9 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 111.103 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.9 m -61.12 -48.25 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.471 HG21 ' O ' ' A' ' 7' ' ' ILE . 13.1 tt 35.08 87.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.628 0.58 . . . . 0.0 111.536 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.598 ' HB3' ' HG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -42.99 148.87 0.54 Allowed Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.329 -179.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.15 -173.11 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.663 2.242 . . . . 0.0 112.612 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 58.16 30.72 19.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.228 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.83 39.27 76.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.501 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.598 ' HG1' ' HB3' ' A' ' 8' ' ' CYS . 30.0 p -114.54 154.45 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.1 t -114.33 155.83 25.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.53 136.46 52.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.148 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.1 p -148.96 154.99 40.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.473 ' HB2' ' CZ2' ' A' ' 22' ' ' TRP . 52.6 tp -82.58 141.42 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.38 152.86 41.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.65 -28.83 48.22 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.588 2.192 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.75 -25.05 23.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.62 55.16 0.42 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.15 141.09 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.248 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.473 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 77.8 m95 -114.9 123.24 48.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.573 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.44 153.12 39.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.945 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -114.84 134.05 55.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.099 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.62 143.74 22.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.848 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.519 ' HD3' HG22 ' A' ' 12' ' ' THR . 90.9 Cg_endo -82.63 89.28 1.17 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.638 2.225 . . . . 0.0 112.502 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.77 32.88 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.983 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.984 0.421 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.44 167.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.98 -26.03 64.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.98 51.38 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.031 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.1 m -137.03 -78.04 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.08 59.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.525 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 3.3 m 59.98 165.78 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.502 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 Cg_endo -49.77 -72.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.585 2.19 . . . . 0.0 112.296 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -158.48 123.32 4.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.99 48.11 87.46 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.202 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -145.21 155.61 43.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 111.165 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.2 t -114.37 155.3 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.608 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -114.18 128.94 56.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.375 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.05 138.31 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.598 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.45 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 32.3 tp -84.3 125.42 32.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.24 156.96 68.82 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.733 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -36.52 15.22 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.73 2.287 . . . . 0.0 112.538 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -75.45 -81.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.766 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.39 36.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.58 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.91 147.53 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.45 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.8 m95 -114.64 122.91 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.212 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -114.36 155.49 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.999 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 13' ' ' THR . 37.7 m -114.36 116.71 29.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.502 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.99 124.38 29.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.01 91.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.57 2.18 . . . . 0.0 112.455 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -123.97 168.7 12.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.614 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.866 0.365 . . . . 0.0 110.9 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -13.32 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.87 -57.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.18 115.33 1.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.413 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 3.2 m -162.29 -39.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.024 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 mt 55.63 62.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.998 0.428 . . . . 0.0 110.649 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.512 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -57.37 161.98 4.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.253 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.52 139.24 44.26 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.796 2.331 . . . . 0.0 112.461 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.47 -162.79 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.0 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.49 63.46 4.43 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.512 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 72.6 p -114.92 155.22 27.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.555 HG21 ' N ' ' A' ' 14' ' ' CYS . 1.2 m -121.61 153.06 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.555 ' N ' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER -113.88 121.96 45.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.951 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -122.24 148.93 44.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.468 ' HB2' ' CZ2' ' A' ' 22' ' ' TRP . 68.5 tp -97.11 113.01 24.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.068 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.45 157.48 72.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.363 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.57 -12.02 7.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.482 2.121 . . . . 0.0 112.453 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -88.75 -67.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.24 50.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.596 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.42 151.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 111.42 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.468 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 91.4 m95 -117.71 131.62 56.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 9.0 p90 -138.21 151.35 47.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.355 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 13' ' ' THR . 1.6 m -125.85 126.53 44.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.712 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.1 m -139.85 152.66 68.56 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -86.04 96.38 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.611 2.207 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -130.24 39.27 3.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.967 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.967 0.413 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.5 161.53 29.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.79 -30.1 63.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 27.95 5.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -136.68 -95.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 mt 58.34 108.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-O 120.869 0.366 . . . . 0.0 111.682 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.493 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 m -59.24 120.26 46.16 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.69 -176.8 1.88 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.872 2.381 . . . . 0.0 112.633 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 55.5 -166.75 0.1 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.225 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.47 44.74 3.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.31 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.493 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -115.2 155.35 27.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.614 0.245 . . . . 0.0 110.855 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 6.0 t -133.31 155.19 49.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.824 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.26 114.73 27.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.026 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 p -140.59 154.23 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.426 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 31.7 tp -84.01 128.99 34.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.564 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -82.55 160.58 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.595 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.31 -8.0 9.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.463 2.108 . . . . 0.0 112.541 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -97.7 -38.74 9.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.879 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 124.16 44.62 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.611 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.564 HG13 ' HB3' ' A' ' 17' ' ' SER . 8.6 p -136.18 149.32 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 111.441 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.461 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 46.6 m95 -114.62 128.48 56.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.351 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -155.06 155.06 33.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.595 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -128.83 122.97 31.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.87 155.67 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.44 78.22 3.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.552 2.168 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -113.77 178.31 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.813 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.492 ' HD1' ' H ' ' A' ' 2' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.794 0.33 . . . . 0.0 111.235 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.492 ' H ' ' HD1' ' A' ' 1' ' ' HIS . 6.4 p -103.11 57.46 0.76 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.09 20.89 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.68 -10.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.34 12.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 41.3 m -143.8 -50.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 54.28 80.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.391 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 72.1 m -70.53 157.23 90.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.523 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.784 ' HB2' HG22 ' A' ' 12' ' ' THR . 73.2 Cg_exo -48.68 162.2 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.518 2.145 . . . . 0.0 112.521 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.62 128.16 34.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.256 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.7 59.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.961 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.784 HG22 ' HB2' ' A' ' 9' ' ' PRO . 24.9 p -133.02 154.13 50.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.9 t -126.46 148.6 49.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.006 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.514 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.8 p -114.8 144.72 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.8 146.49 43.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.649 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.413 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 63.1 tp -78.37 137.23 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.5 156.81 38.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.22 -8.33 14.16 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.444 2.096 . . . . 0.0 112.293 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -98.43 -22.66 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.654 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.22 43.51 1.49 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.415 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.75 148.87 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.213 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.413 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 92.1 m95 -117.51 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 10.5 p90 -143.37 148.75 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -114.47 149.06 36.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.031 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 85.8 p -137.19 138.75 26.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 6.2 Cg_exo -78.75 20.41 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.02 2.48 . . . . 0.0 112.517 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -140.41 35.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.404 ' HA ' ' CG2' ' A' ' 13' ' ' THR . 3.0 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.434 ' ND1' ' H ' ' A' ' 2' ' ' CYS . 1.9 t60 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.746 0.308 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.434 ' H ' ' ND1' ' A' ' 1' ' ' HIS . 0.4 OUTLIER -92.21 90.28 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.981 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -160.67 114.64 2.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.5 42.86 26.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.87 -49.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -113.61 -61.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.6 mt 64.58 107.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.07 162.23 62.72 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.658 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.09 149.76 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.596 2.197 . . . . 0.0 112.562 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -62.86 135.61 57.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.88 9.68 85.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.645 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -126.61 150.36 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 0.0 111.242 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.1 t -120.06 152.34 37.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 p -114.72 126.61 55.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.3 147.78 42.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.808 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.03 116.26 21.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.94 156.97 86.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.693 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.91 -11.7 13.0 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.55 2.167 . . . . 0.0 112.207 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.23 -41.66 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.725 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.54 39.44 0.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.317 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' N ' ' A' ' 22' ' ' TRP . 12.4 p -129.55 152.54 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 0.0 111.173 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' N ' HG23 ' A' ' 21' ' ' VAL . 84.6 m95 -114.2 119.64 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 4.3 p90 -127.04 145.73 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -119.04 135.39 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.905 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.8 133.28 9.73 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.02 98.83 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.148 . . . . 0.0 112.564 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -135.66 179.99 6.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.924 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.42 ' HD1' ' H ' ' A' ' 2' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.856 0.36 . . . . 0.0 111.274 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.42 ' H ' ' HD1' ' A' ' 1' ' ' HIS . 31.8 p -117.37 -162.04 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.68 32.56 18.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.16 -19.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.58 -38.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.2 m -94.38 -63.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.9 mt 64.78 124.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.571 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -74.95 152.0 86.52 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.93 136.85 22.8 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 61.88 -170.01 0.17 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.963 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 68.02 2.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.274 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.6 p -130.9 155.65 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -114.2 152.68 30.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.568 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -114.55 147.04 40.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.113 0.482 . . . . 0.0 111.506 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.04 148.7 30.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.347 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.43 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 46.5 tp -93.0 109.1 20.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.222 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.31 162.29 73.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -61.62 -11.1 18.83 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.369 2.046 . . . . 0.0 112.351 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -92.72 5.7 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.67 50.4 36.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.454 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.88 150.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.35 . . . . 0.0 111.314 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.43 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 87.0 m95 -117.8 122.77 44.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.582 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.2 150.37 39.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -118.94 143.84 46.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.743 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -124.46 136.63 28.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.162 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 10.3 Cg_exo -71.66 -18.85 28.53 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.902 2.401 . . . . 0.0 112.31 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 57.6 43.84 21.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.868 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.413 ' HE1' ' HA ' ' A' ' 15' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.953 0.406 . . . . 0.0 111.157 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 14' ' ' CYS . 69.3 m -60.44 100.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.113 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.66 178.27 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 54.4 -151.39 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.079 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.05 75.45 4.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.286 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -130.0 -72.59 0.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.073 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt 49.22 73.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.397 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 1.7 m -69.45 168.11 18.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.535 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.634 ' HB2' HG22 ' A' ' 12' ' ' THR . 90.2 Cg_exo -44.98 152.78 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.445 2.097 . . . . 0.0 112.651 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -22.67 61.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.588 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 26' ' ' PRO . . . -102.39 19.21 49.05 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.729 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.634 HG22 ' HB2' ' A' ' 9' ' ' PRO . 27.9 p -137.28 155.42 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.36 . . . . 0.0 111.093 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.566 HG21 ' HZ ' ' A' ' 27' ' ' PHE . 10.8 t -115.51 156.42 25.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.356 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 12.0 m -113.67 127.96 56.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.413 ' HA ' ' HE1' ' A' ' 1' ' ' HIS . 2.4 m -142.6 141.6 32.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.445 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 62.4 tp -98.44 108.3 20.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.71 156.6 63.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.706 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.87 -17.13 22.53 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.54 2.16 . . . . 0.0 112.39 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -83.9 -33.88 24.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.71 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.41 ' HA2' HD13 ' A' ' 16' ' ' LEU . . . 114.44 44.83 0.7 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.319 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.81 152.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.022 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.445 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.2 m95 -114.81 128.53 56.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.527 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -129.0 150.46 50.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.225 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 84.8 m -144.15 120.27 10.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.793 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 t -131.13 144.39 53.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 11' ' ' GLY . 98.3 Cg_endo -79.9 133.37 10.12 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.573 2.182 . . . . 0.0 112.304 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.566 ' HZ ' HG21 ' A' ' 13' ' ' THR . 0.3 OUTLIER -101.15 99.47 9.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.986 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.805 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.6 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . 7.3 p80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.664 0.269 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.458 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 24.3 p -57.25 108.32 0.52 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -153.34 108.24 3.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 57.48 37.38 27.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 -26.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 99.4 m -110.05 -53.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 mt 60.67 91.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -83.31 165.68 39.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.136 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.685 ' HB2' HG23 ' A' ' 12' ' ' THR . 81.9 Cg_exo -42.07 133.4 4.4 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.449 2.1 . . . . 0.0 112.365 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -50.48 119.98 4.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.4 10.59 50.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.617 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.685 HG23 ' HB2' ' A' ' 9' ' ' PRO . 6.9 p -129.31 150.24 50.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.299 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -119.95 143.43 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.76 146.35 41.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 111.351 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.49 137.09 15.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 57.5 tp -64.39 132.72 50.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 153.43 46.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.431 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.58 -14.88 18.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.084 . . . . 0.0 112.277 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -88.62 -32.02 18.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.69 46.31 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.854 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.22 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.6 ' HZ3' ' HB2' ' A' ' 1' ' ' HIS . 87.1 m95 -116.44 124.24 49.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.174 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -149.59 144.72 26.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.458 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -117.61 132.79 56.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.629 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -117.44 136.99 23.7 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.227 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.75 2.14 8.75 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.377 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 61.44 -179.06 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.164 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.87 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.796 0.332 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.538 ' HA ' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -156.49 4.85 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.006 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.86 5.85 41.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.007 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.44 -71.56 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.462 ' O ' HG22 ' A' ' 6' ' ' THR . . . -135.6 -57.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.538 ' HB ' ' HA ' ' A' ' 2' ' ' CYS . 5.1 t 42.43 -159.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.973 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 pt -141.07 43.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 65.6 m -113.68 152.19 45.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.731 ' HB2' HG21 ' A' ' 12' ' ' THR . 55.1 Cg_exo -52.19 170.83 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.764 2.309 . . . . 0.0 112.788 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 118.36 12.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.4 30.18 28.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.74 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.731 HG21 ' HB2' ' A' ' 9' ' ' PRO . 63.0 p -130.45 154.69 47.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.064 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.1 t -121.08 155.41 34.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.619 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.7 p -114.22 134.92 54.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.937 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.86 147.55 31.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -84.73 138.2 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.66 158.79 32.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.73 -0.57 3.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.457 2.104 . . . . 0.0 112.649 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -104.06 -14.66 15.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.26 3.87 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.87 150.66 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 0.0 111.182 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.407 ' CE2' ' HG ' ' A' ' 16' ' ' LEU . 87.3 m95 -114.88 141.6 47.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.49 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -152.96 153.58 33.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 13' ' ' THR . 4.6 m -114.79 119.17 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.93 141.38 41.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.33 31.96 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.695 2.264 . . . . 0.0 112.834 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -161.02 40.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 111.036 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.449 ' HA ' HG22 ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.891 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.612 0.244 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.2 m -52.37 101.37 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.923 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.63 107.44 16.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.184 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 50.66 -98.99 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.534 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.55 50.61 0.9 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 111.103 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.9 m -61.12 -48.25 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.471 HG21 ' O ' ' A' ' 7' ' ' ILE . 13.1 tt 35.08 87.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.628 0.58 . . . . 0.0 111.536 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.598 ' HB3' ' HG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -42.99 148.87 0.54 Allowed Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.329 -179.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.15 -173.11 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.663 2.242 . . . . 0.0 112.612 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 58.16 30.72 19.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.228 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.83 39.27 76.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.501 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.598 ' HG1' ' HB3' ' A' ' 8' ' ' CYS . 30.0 p -114.54 154.45 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.1 t -114.33 155.83 25.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.53 136.46 52.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.148 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.1 p -148.96 154.99 40.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.473 ' HB2' ' CZ2' ' A' ' 22' ' ' TRP . 52.6 tp -82.58 141.42 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.38 152.86 41.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.65 -28.83 48.22 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.588 2.192 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.75 -25.05 23.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.62 55.16 0.42 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.401 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.15 141.09 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.248 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.473 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 77.8 m95 -114.9 123.24 48.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.573 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.44 153.12 39.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.945 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -114.84 134.05 55.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.099 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.62 143.74 22.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.848 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.519 ' HD3' HG22 ' A' ' 12' ' ' THR . 90.9 Cg_endo -82.63 89.28 1.17 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.638 2.225 . . . . 0.0 112.502 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.77 32.88 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.983 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.628 0.252 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 m -51.61 104.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.969 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.44 167.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.98 -26.03 64.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.98 51.38 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.031 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.1 m -137.03 -78.04 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.08 59.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.525 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 3.3 m 59.98 165.78 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.502 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 Cg_endo -49.77 -72.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.585 2.19 . . . . 0.0 112.296 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -158.48 123.32 4.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.99 48.11 87.46 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.202 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 0.2 OUTLIER -145.21 155.61 43.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 111.165 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.2 t -114.37 155.3 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.608 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -114.18 128.94 56.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.375 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.05 138.31 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.598 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.45 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 32.3 tp -84.3 125.42 32.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.24 156.96 68.82 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.733 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -36.52 15.22 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.73 2.287 . . . . 0.0 112.538 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -75.45 -81.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.766 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.39 36.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.58 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.91 147.53 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.45 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.8 m95 -114.64 122.91 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.212 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -114.36 155.49 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.999 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 13' ' ' THR . 37.7 m -114.36 116.71 29.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.502 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.99 124.38 29.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.01 91.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.57 2.18 . . . . 0.0 112.455 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -123.97 168.7 12.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.472 ' H2 ' ' HA ' ' A' ' 7' ' ' ILE . 2.0 t-80 . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.844 0.354 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.614 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -154.91 -157.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.9 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -13.32 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.87 -57.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.18 115.33 1.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.413 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 3.2 m -162.29 -39.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.024 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.472 ' HA ' ' H2 ' ' A' ' 1' ' ' HIS . 1.5 mt 55.63 62.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.998 0.428 . . . . 0.0 110.649 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.512 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -57.37 161.98 4.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.253 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.52 139.24 44.26 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.796 2.331 . . . . 0.0 112.461 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.47 -162.79 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.0 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.49 63.46 4.43 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.512 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 72.6 p -114.92 155.22 27.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.555 HG21 ' N ' ' A' ' 14' ' ' CYS . 1.2 m -121.61 153.06 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.555 ' N ' HG21 ' A' ' 13' ' ' THR . 0.0 OUTLIER -113.88 121.96 45.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.951 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -122.24 148.93 44.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.468 ' HB2' ' CZ2' ' A' ' 22' ' ' TRP . 68.5 tp -97.11 113.01 24.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.068 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.45 157.48 72.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.363 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.57 -12.02 7.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.482 2.121 . . . . 0.0 112.453 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -88.75 -67.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.24 50.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.596 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.42 151.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 111.42 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.468 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 91.4 m95 -117.71 131.62 56.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 9.0 p90 -138.21 151.35 47.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.355 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 13' ' ' THR . 1.6 m -125.85 126.53 44.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.712 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.1 m -139.85 152.66 68.56 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -86.04 96.38 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.611 2.207 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -130.24 39.27 3.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.967 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.461 ' HB3' ' CE3' ' A' ' 22' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.614 0.245 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -48.2 96.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.102 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.5 161.53 29.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.79 -30.1 63.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 27.95 5.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -136.68 -95.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 mt 58.34 108.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-O 120.869 0.366 . . . . 0.0 111.682 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.493 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 m -59.24 120.26 46.16 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.69 -176.8 1.88 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.872 2.381 . . . . 0.0 112.633 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 55.5 -166.75 0.1 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.225 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.47 44.74 3.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.31 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.493 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -115.2 155.35 27.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.614 0.245 . . . . 0.0 110.855 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 6.0 t -133.31 155.19 49.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.824 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.26 114.73 27.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.026 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 p -140.59 154.23 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.426 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 31.7 tp -84.01 128.99 34.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.564 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -82.55 160.58 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.595 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.31 -8.0 9.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.463 2.108 . . . . 0.0 112.541 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -97.7 -38.74 9.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.879 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 124.16 44.62 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.611 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.564 HG13 ' HB3' ' A' ' 17' ' ' SER . 8.6 p -136.18 149.32 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 111.441 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.461 ' CE3' ' HB3' ' A' ' 1' ' ' HIS . 46.6 m95 -114.62 128.48 56.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.351 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -155.06 155.06 33.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.595 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -128.83 122.97 31.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.87 155.67 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.44 78.22 3.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.552 2.168 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -113.77 178.31 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.813 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 6.4 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.918 0.39 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.09 20.89 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.68 -10.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.34 12.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 41.3 m -143.8 -50.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 54.28 80.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.391 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 72.1 m -70.53 157.23 90.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.523 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HB2' HG21 ' A' ' 12' ' ' THR . 73.2 Cg_exo -48.68 162.2 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.518 2.145 . . . . 0.0 112.521 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.62 128.16 34.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.256 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.7 59.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.961 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.534 HG21 ' HB2' ' A' ' 9' ' ' PRO . 24.9 p -133.02 154.13 50.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.9 t -126.46 148.6 49.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.006 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.8 p -114.8 144.72 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.8 146.49 43.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.649 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.424 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 63.1 tp -78.37 137.23 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.5 156.81 38.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.22 -8.33 14.16 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.444 2.096 . . . . 0.0 112.293 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -98.43 -22.66 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.654 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.22 43.51 1.49 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.415 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.75 148.87 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.213 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 92.1 m95 -117.51 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 10.5 p90 -143.37 148.75 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -114.47 149.06 36.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.031 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 85.8 p -137.19 138.75 26.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 6.2 Cg_exo -78.75 20.41 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.02 2.48 . . . . 0.0 112.517 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -140.41 35.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.417 ' HA ' ' CG2' ' A' ' 13' ' ' THR . 3.0 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.825 0.345 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -160.67 114.64 2.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.5 42.86 26.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.87 -49.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -113.61 -61.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.6 mt 64.58 107.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.07 162.23 62.72 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.658 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.09 149.76 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.596 2.197 . . . . 0.0 112.562 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -62.86 135.61 57.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.88 9.68 85.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.645 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -126.61 150.36 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 0.0 111.242 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.1 t -120.06 152.34 37.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 p -114.72 126.61 55.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.3 147.78 42.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.808 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -82.03 116.26 21.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.94 156.97 86.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.693 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.91 -11.7 13.0 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.55 2.167 . . . . 0.0 112.207 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.23 -41.66 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.725 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.54 39.44 0.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.317 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.55 152.54 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 0.0 111.173 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.407 ' CE2' ' HG ' ' A' ' 16' ' ' LEU . 84.6 m95 -114.2 119.64 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 4.3 p90 -127.04 145.73 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -119.04 135.39 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.905 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.8 133.28 9.73 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.02 98.83 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.148 . . . . 0.0 112.564 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -135.66 179.99 6.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.924 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.422 ' HB2' ' H ' ' A' ' 7' ' ' ILE . 31.8 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.511 0.196 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.68 32.56 18.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.16 -19.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.58 -38.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.2 m -94.38 -63.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.422 ' H ' ' HB2' ' A' ' 2' ' ' CYS . 20.9 mt 64.78 124.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.571 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -74.95 152.0 86.52 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.93 136.85 22.8 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 61.88 -170.01 0.17 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.963 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 68.02 2.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.274 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 26' ' ' PRO . 69.6 p -130.9 155.65 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -114.2 152.68 30.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.568 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -114.55 147.04 40.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.113 0.482 . . . . 0.0 111.506 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.04 148.7 30.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.347 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.465 HD13 ' CE2' ' A' ' 22' ' ' TRP . 46.5 tp -93.0 109.1 20.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.222 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.31 162.29 73.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -61.62 -11.1 18.83 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.369 2.046 . . . . 0.0 112.351 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -92.72 5.7 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 68.67 50.4 36.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.454 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.88 150.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.35 . . . . 0.0 111.314 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.465 ' CE2' HD13 ' A' ' 16' ' ' LEU . 87.0 m95 -117.8 122.77 44.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.582 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.2 150.37 39.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -118.94 143.84 46.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.743 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -124.46 136.63 28.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.162 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.689 ' HA ' HG22 ' A' ' 12' ' ' THR . 10.3 Cg_exo -71.66 -18.85 28.53 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.902 2.401 . . . . 0.0 112.31 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 57.6 43.84 21.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.868 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 14' ' ' CYS . 69.3 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.841 0.353 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.66 178.27 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 54.4 -151.39 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.079 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.05 75.45 4.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.286 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -130.0 -72.59 0.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.073 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt 49.22 73.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.397 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.7 m -69.45 168.11 18.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.535 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HB2' HG23 ' A' ' 12' ' ' THR . 90.2 Cg_exo -44.98 152.78 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.445 2.097 . . . . 0.0 112.651 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -22.67 61.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.588 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' PRO . . . -102.39 19.21 49.05 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.729 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 27.9 p -137.28 155.42 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.36 . . . . 0.0 111.093 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.419 HG22 ' HZ ' ' A' ' 27' ' ' PHE . 10.8 t -115.51 156.42 25.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.356 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 12.0 m -113.67 127.96 56.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 m -142.6 141.6 32.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 62.4 tp -98.44 108.3 20.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.71 156.6 63.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.706 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.87 -17.13 22.53 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.54 2.16 . . . . 0.0 112.39 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -83.9 -33.88 24.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.71 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.442 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 114.44 44.83 0.7 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.319 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.81 152.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.022 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.2 m95 -114.81 128.53 56.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.527 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -129.0 150.46 50.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.225 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 84.8 m -144.15 120.27 10.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.793 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 t -131.13 144.39 53.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' GLY . 98.3 Cg_endo -79.9 133.37 10.12 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.573 2.182 . . . . 0.0 112.304 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.419 ' HZ ' HG22 ' A' ' 13' ' ' THR . 0.3 OUTLIER -101.15 99.47 9.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.986 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.805 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 24.3 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -153.34 108.24 3.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 57.48 37.38 27.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 -26.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 99.4 m -110.05 -53.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 mt 60.67 91.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -83.31 165.68 39.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.136 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.07 133.4 4.4 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.449 2.1 . . . . 0.0 112.365 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -50.48 119.98 4.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.4 10.59 50.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.617 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.488 HG22 ' CA ' ' A' ' 26' ' ' PRO . 6.9 p -129.31 150.24 50.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.299 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -119.95 143.43 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.76 146.35 41.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 111.351 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.49 137.09 15.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 57.5 tp -64.39 132.72 50.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 153.43 46.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.431 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.58 -14.88 18.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.084 . . . . 0.0 112.277 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -88.62 -32.02 18.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.69 46.31 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.854 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.22 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.448 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 87.1 m95 -116.44 124.24 49.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.174 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -149.59 144.72 26.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.458 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -117.61 132.79 56.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.629 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -117.44 136.99 23.7 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.227 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.488 ' CA ' HG22 ' A' ' 12' ' ' THR . 86.1 Cg_endo -81.75 2.14 8.75 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.377 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 61.44 -179.06 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.164 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.87 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.55 ' HA ' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.666 0.269 . . . . 0.0 111.006 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.86 5.85 41.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.007 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.44 -71.56 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.6 -57.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 8' ' ' CYS . 5.1 t 42.43 -159.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.973 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.465 ' N ' HG23 ' A' ' 6' ' ' THR . 4.8 pt -141.07 43.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 65.6 m -113.68 152.19 45.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.19 170.83 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.764 2.309 . . . . 0.0 112.788 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 118.36 12.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.4 30.18 28.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.74 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 63.0 p -130.45 154.69 47.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.064 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.1 t -121.08 155.41 34.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.7 p -114.22 134.92 54.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.937 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.86 147.55 31.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -84.73 138.2 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.424 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.66 158.79 32.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.73 -0.57 3.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.457 2.104 . . . . 0.0 112.649 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -104.06 -14.66 15.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.26 3.87 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.87 150.66 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 0.0 111.182 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CE2' ' HG ' ' A' ' 16' ' ' LEU . 87.3 m95 -114.88 141.6 47.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.49 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -152.96 153.58 33.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 13' ' ' THR . 4.6 m -114.79 119.17 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.93 141.38 41.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.33 31.96 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.695 2.264 . . . . 0.0 112.834 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -161.02 40.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 111.036 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.451 ' HA ' HG21 ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.891 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.961 0.41 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.63 107.44 16.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.184 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 50.66 -98.99 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.534 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.55 50.61 0.9 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 111.103 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.9 m -61.12 -48.25 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 7' ' ' ILE . 13.1 tt 35.08 87.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.628 0.58 . . . . 0.0 111.536 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -42.99 148.87 0.54 Allowed Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.329 -179.552 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.15 -173.11 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.663 2.242 . . . . 0.0 112.612 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 58.16 30.72 19.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.228 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.83 39.27 76.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.501 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 30.0 p -114.54 154.45 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.1 t -114.33 155.83 25.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.53 136.46 52.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.148 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.1 p -148.96 154.99 40.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.557 HD11 ' HA2' ' A' ' 20' ' ' GLY . 52.6 tp -82.58 141.42 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.38 152.86 41.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.65 -28.83 48.22 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.588 2.192 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.75 -25.05 23.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 113.62 55.16 0.42 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.401 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.15 141.09 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.248 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.479 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 77.8 m95 -114.9 123.24 48.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.573 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.44 153.12 39.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.945 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -114.84 134.05 55.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.099 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.62 143.74 22.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.848 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.63 89.28 1.17 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.638 2.225 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.77 32.88 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.983 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.984 0.421 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.44 167.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.98 -26.03 64.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.98 51.38 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.031 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.1 m -137.03 -78.04 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.08 59.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 3.3 m 59.98 165.78 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.531 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 Cg_endo -49.77 -72.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.585 2.19 . . . . 0.0 112.296 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -158.48 123.32 4.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.99 48.11 87.46 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.202 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.552 HG22 ' C ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -145.21 155.61 43.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 111.165 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.2 t -114.37 155.3 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.608 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -114.18 128.94 56.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.375 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.05 138.31 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.598 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 32.3 tp -84.3 125.42 32.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.24 156.96 68.82 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.733 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -36.52 15.22 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.73 2.287 . . . . 0.0 112.538 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -75.45 -81.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.766 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.39 36.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.58 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.91 147.53 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.8 m95 -114.64 122.91 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.212 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -114.36 155.49 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.999 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 13' ' ' THR . 37.7 m -114.36 116.71 29.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.502 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.552 ' C ' HG22 ' A' ' 12' ' ' THR . 0.1 OUTLIER -115.99 124.38 29.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.42 ' N ' HG22 ' A' ' 12' ' ' THR . 97.1 Cg_endo -81.01 91.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.57 2.18 . . . . 0.0 112.455 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -123.97 168.7 12.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.623 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.866 0.365 . . . . 0.0 110.9 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -13.32 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.87 -57.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.18 115.33 1.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.413 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.623 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 3.2 m -162.29 -39.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.024 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 mt 55.63 62.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.998 0.428 . . . . 0.0 110.649 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.521 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -57.37 161.98 4.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.253 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.52 139.24 44.26 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.796 2.331 . . . . 0.0 112.461 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.47 -162.79 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.0 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.49 63.46 4.43 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.521 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 72.6 p -114.92 155.22 27.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 1.2 m -121.61 153.06 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -113.88 121.96 45.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.951 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -122.24 148.93 44.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 22' ' ' TRP . 68.5 tp -97.11 113.01 24.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.068 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.45 157.48 72.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.363 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.57 -12.02 7.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.482 2.121 . . . . 0.0 112.453 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -88.75 -67.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.24 50.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.596 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.42 151.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 111.42 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 91.4 m95 -117.71 131.62 56.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 9.0 p90 -138.21 151.35 47.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.355 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' THR . 1.6 m -125.85 126.53 44.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.712 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.1 m -139.85 152.66 68.56 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -86.04 96.38 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.611 2.207 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -130.24 39.27 3.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.967 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.967 0.413 . . . . 0.0 111.102 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.5 161.53 29.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.79 -30.1 63.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 27.95 5.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -136.68 -95.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.433 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 5.5 mt 58.34 108.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-O 120.869 0.366 . . . . 0.0 111.682 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 m -59.24 120.26 46.16 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' CYS . 11.8 Cg_exo -70.69 -176.8 1.88 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.872 2.381 . . . . 0.0 112.633 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 55.5 -166.75 0.1 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.225 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.47 44.74 3.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.31 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -115.2 155.35 27.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.614 0.245 . . . . 0.0 110.855 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 6.0 t -133.31 155.19 49.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.824 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.26 114.73 27.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.026 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 p -140.59 154.23 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.426 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.755 HD11 ' HA2' ' A' ' 20' ' ' GLY . 31.7 tp -84.01 128.99 34.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.55 160.58 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.595 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.31 -8.0 9.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.463 2.108 . . . . 0.0 112.541 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -97.7 -38.74 9.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.879 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.755 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 124.16 44.62 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.611 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.18 149.32 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 111.441 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 46.6 m95 -114.62 128.48 56.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.351 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -155.06 155.06 33.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.595 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -128.83 122.97 31.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.87 155.67 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.44 78.22 3.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.552 2.168 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -113.77 178.31 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.813 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.794 0.33 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 6.4 p -103.11 57.46 0.76 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.09 20.89 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.68 -10.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.34 12.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 41.3 m -143.8 -50.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 54.28 80.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.391 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 72.1 m -70.53 157.23 90.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.523 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HB2' HG21 ' A' ' 12' ' ' THR . 73.2 Cg_exo -48.68 162.2 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.518 2.145 . . . . 0.0 112.521 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.62 128.16 34.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.256 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.7 59.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.961 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.534 HG21 ' HB2' ' A' ' 9' ' ' PRO . 24.9 p -133.02 154.13 50.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.9 t -126.46 148.6 49.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.006 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.8 p -114.8 144.72 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.8 146.49 43.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.649 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.424 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 63.1 tp -78.37 137.23 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.5 156.81 38.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.22 -8.33 14.16 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.444 2.096 . . . . 0.0 112.293 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -98.43 -22.66 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.654 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.22 43.51 1.49 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.415 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.75 148.87 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.213 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 92.1 m95 -117.51 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 10.5 p90 -143.37 148.75 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -114.47 149.06 36.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.031 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 85.8 p -137.19 138.75 26.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 6.2 Cg_exo -78.75 20.41 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.02 2.48 . . . . 0.0 112.517 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -140.41 35.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.417 ' HA ' ' CG2' ' A' ' 13' ' ' THR . 3.0 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.746 0.308 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -92.21 90.28 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.981 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -160.67 114.64 2.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.5 42.86 26.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.87 -49.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -113.61 -61.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.6 mt 64.58 107.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.07 162.23 62.72 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.658 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.09 149.76 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.596 2.197 . . . . 0.0 112.562 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -62.86 135.61 57.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.88 9.68 85.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.645 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -126.61 150.36 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 0.0 111.242 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.1 t -120.06 152.34 37.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 p -114.72 126.61 55.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.3 147.78 42.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.808 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -82.03 116.26 21.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.94 156.97 86.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.693 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.91 -11.7 13.0 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.55 2.167 . . . . 0.0 112.207 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.23 -41.66 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.725 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.54 39.44 0.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.317 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.55 152.54 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 0.0 111.173 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.407 ' CE2' ' HG ' ' A' ' 16' ' ' LEU . 84.6 m95 -114.2 119.64 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 4.3 p90 -127.04 145.73 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -119.04 135.39 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.905 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.8 133.28 9.73 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.02 98.83 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.148 . . . . 0.0 112.564 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -135.66 179.99 6.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.924 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.856 0.36 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.422 ' HB2' ' H ' ' A' ' 7' ' ' ILE . 31.8 p -117.37 -162.04 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.68 32.56 18.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.16 -19.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.58 -38.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.2 m -94.38 -63.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.422 ' H ' ' HB2' ' A' ' 2' ' ' CYS . 20.9 mt 64.78 124.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.571 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -74.95 152.0 86.52 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.93 136.85 22.8 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 61.88 -170.01 0.17 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.963 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 68.02 2.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.274 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 26' ' ' PRO . 69.6 p -130.9 155.65 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -114.2 152.68 30.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.568 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -114.55 147.04 40.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.113 0.482 . . . . 0.0 111.506 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.04 148.7 30.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.347 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.465 HD13 ' CE2' ' A' ' 22' ' ' TRP . 46.5 tp -93.0 109.1 20.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.222 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.31 162.29 73.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -61.62 -11.1 18.83 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.369 2.046 . . . . 0.0 112.351 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -92.72 5.7 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 68.67 50.4 36.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.454 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.88 150.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.35 . . . . 0.0 111.314 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.465 ' CE2' HD13 ' A' ' 16' ' ' LEU . 87.0 m95 -117.8 122.77 44.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.582 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.2 150.37 39.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -118.94 143.84 46.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.743 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -124.46 136.63 28.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.162 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.689 ' HA ' HG22 ' A' ' 12' ' ' THR . 10.3 Cg_exo -71.66 -18.85 28.53 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.902 2.401 . . . . 0.0 112.31 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 57.6 43.84 21.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.868 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.425 ' HE1' ' HA ' ' A' ' 15' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.953 0.406 . . . . 0.0 111.157 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 14' ' ' CYS . 69.3 m -60.44 100.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.113 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.66 178.27 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 54.4 -151.39 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.079 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.05 75.45 4.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.286 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -130.0 -72.59 0.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.073 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt 49.22 73.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.397 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.7 m -69.45 168.11 18.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.535 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HB2' HG23 ' A' ' 12' ' ' THR . 90.2 Cg_exo -44.98 152.78 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.445 2.097 . . . . 0.0 112.651 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -22.67 61.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.588 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' PRO . . . -102.39 19.21 49.05 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.729 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 27.9 p -137.28 155.42 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.36 . . . . 0.0 111.093 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.419 HG22 ' HZ ' ' A' ' 27' ' ' PHE . 10.8 t -115.51 156.42 25.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.356 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 12.0 m -113.67 127.96 56.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.425 ' HA ' ' HE1' ' A' ' 1' ' ' HIS . 2.4 m -142.6 141.6 32.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 62.4 tp -98.44 108.3 20.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.71 156.6 63.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.706 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.87 -17.13 22.53 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.54 2.16 . . . . 0.0 112.39 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -83.9 -33.88 24.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.71 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.442 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 114.44 44.83 0.7 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.319 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.81 152.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.022 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.2 m95 -114.81 128.53 56.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.527 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -129.0 150.46 50.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.225 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 84.8 m -144.15 120.27 10.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.793 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 t -131.13 144.39 53.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' GLY . 98.3 Cg_endo -79.9 133.37 10.12 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.573 2.182 . . . . 0.0 112.304 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.419 ' HZ ' HG22 ' A' ' 13' ' ' THR . 0.3 OUTLIER -101.15 99.47 9.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.986 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.805 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.61 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . 7.3 p80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.664 0.269 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 24.3 p -57.25 108.32 0.52 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -153.34 108.24 3.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 57.48 37.38 27.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 -26.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 99.4 m -110.05 -53.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 mt 60.67 91.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -83.31 165.68 39.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.136 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.07 133.4 4.4 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.449 2.1 . . . . 0.0 112.365 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -50.48 119.98 4.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.4 10.59 50.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.617 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.488 HG22 ' CA ' ' A' ' 26' ' ' PRO . 6.9 p -129.31 150.24 50.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.299 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -119.95 143.43 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.76 146.35 41.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 111.351 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.49 137.09 15.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 57.5 tp -64.39 132.72 50.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 153.43 46.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.431 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.58 -14.88 18.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.084 . . . . 0.0 112.277 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -88.62 -32.02 18.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.69 46.31 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.854 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.22 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.61 ' HZ3' ' HB2' ' A' ' 1' ' ' HIS . 87.1 m95 -116.44 124.24 49.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.174 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -149.59 144.72 26.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.458 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -117.61 132.79 56.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.629 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -117.44 136.99 23.7 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.227 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.488 ' CA ' HG22 ' A' ' 12' ' ' THR . 86.1 Cg_endo -81.75 2.14 8.75 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.377 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 61.44 -179.06 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.164 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.87 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.796 0.332 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.55 ' HA ' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -156.49 4.85 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.006 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.86 5.85 41.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.007 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.44 -71.56 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.6 -57.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 8' ' ' CYS . 5.1 t 42.43 -159.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.973 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.465 ' N ' HG23 ' A' ' 6' ' ' THR . 4.8 pt -141.07 43.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 65.6 m -113.68 152.19 45.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.19 170.83 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.764 2.309 . . . . 0.0 112.788 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 118.36 12.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.4 30.18 28.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.74 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 63.0 p -130.45 154.69 47.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.064 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.1 t -121.08 155.41 34.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.7 p -114.22 134.92 54.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.937 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.86 147.55 31.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -84.73 138.2 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.424 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.66 158.79 32.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.73 -0.57 3.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.457 2.104 . . . . 0.0 112.649 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -104.06 -14.66 15.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.26 3.87 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.87 150.66 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 0.0 111.182 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CE2' ' HG ' ' A' ' 16' ' ' LEU . 87.3 m95 -114.88 141.6 47.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.49 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -152.96 153.58 33.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 13' ' ' THR . 4.6 m -114.79 119.17 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.93 141.38 41.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.33 31.96 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.695 2.264 . . . . 0.0 112.834 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -161.02 40.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 111.036 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.451 ' HA ' HG21 ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.891 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.612 0.244 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.2 m -52.37 101.37 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.923 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.63 107.44 16.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.184 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 50.66 -98.99 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.534 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.55 50.61 0.9 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 111.103 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.9 m -61.12 -48.25 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 7' ' ' ILE . 13.1 tt 35.08 87.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.628 0.58 . . . . 0.0 111.536 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -42.99 148.87 0.54 Allowed Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.329 -179.552 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.15 -173.11 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.663 2.242 . . . . 0.0 112.612 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 58.16 30.72 19.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.228 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.83 39.27 76.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.501 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 30.0 p -114.54 154.45 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.1 t -114.33 155.83 25.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.53 136.46 52.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.148 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.1 p -148.96 154.99 40.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.557 HD11 ' HA2' ' A' ' 20' ' ' GLY . 52.6 tp -82.58 141.42 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.38 152.86 41.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.65 -28.83 48.22 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.588 2.192 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.75 -25.05 23.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 113.62 55.16 0.42 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.401 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.15 141.09 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.248 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.479 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 77.8 m95 -114.9 123.24 48.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.573 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.44 153.12 39.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.945 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -114.84 134.05 55.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.099 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.62 143.74 22.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.848 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.63 89.28 1.17 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.638 2.225 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.77 32.88 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.983 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.628 0.252 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 m -51.61 104.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.969 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.44 167.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.98 -26.03 64.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.98 51.38 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.031 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.1 m -137.03 -78.04 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.08 59.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 3.3 m 59.98 165.78 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.531 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 Cg_endo -49.77 -72.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.585 2.19 . . . . 0.0 112.296 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -158.48 123.32 4.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.99 48.11 87.46 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.202 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.552 HG22 ' C ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -145.21 155.61 43.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 111.165 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.2 t -114.37 155.3 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.608 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -114.18 128.94 56.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.375 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.05 138.31 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.598 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 32.3 tp -84.3 125.42 32.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.24 156.96 68.82 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.733 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -36.52 15.22 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.73 2.287 . . . . 0.0 112.538 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -75.45 -81.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.766 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.39 36.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.58 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.91 147.53 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.8 m95 -114.64 122.91 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.212 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -114.36 155.49 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.999 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 13' ' ' THR . 37.7 m -114.36 116.71 29.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.502 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.552 ' C ' HG22 ' A' ' 12' ' ' THR . 0.1 OUTLIER -115.99 124.38 29.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.42 ' N ' HG22 ' A' ' 12' ' ' THR . 97.1 Cg_endo -81.01 91.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.57 2.18 . . . . 0.0 112.455 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -123.97 168.7 12.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.844 0.354 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.623 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -154.91 -157.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.9 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -13.32 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.87 -57.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.18 115.33 1.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.413 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.623 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 3.2 m -162.29 -39.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.024 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 mt 55.63 62.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.998 0.428 . . . . 0.0 110.649 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.521 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -57.37 161.98 4.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.253 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.52 139.24 44.26 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.796 2.331 . . . . 0.0 112.461 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.47 -162.79 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.0 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.49 63.46 4.43 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.521 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 72.6 p -114.92 155.22 27.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 1.2 m -121.61 153.06 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -113.88 121.96 45.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.951 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -122.24 148.93 44.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 22' ' ' TRP . 68.5 tp -97.11 113.01 24.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.068 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.45 157.48 72.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.363 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.57 -12.02 7.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.482 2.121 . . . . 0.0 112.453 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -88.75 -67.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.24 50.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.596 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.42 151.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 111.42 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 91.4 m95 -117.71 131.62 56.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 9.0 p90 -138.21 151.35 47.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.355 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' THR . 1.6 m -125.85 126.53 44.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.712 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.1 m -139.85 152.66 68.56 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -86.04 96.38 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.611 2.207 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -130.24 39.27 3.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.967 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.479 ' HB3' ' CE3' ' A' ' 22' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.614 0.245 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -48.2 96.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.102 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.5 161.53 29.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.79 -30.1 63.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 27.95 5.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -136.68 -95.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.433 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 5.5 mt 58.34 108.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-O 120.869 0.366 . . . . 0.0 111.682 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 m -59.24 120.26 46.16 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' CYS . 11.8 Cg_exo -70.69 -176.8 1.88 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.872 2.381 . . . . 0.0 112.633 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 55.5 -166.75 0.1 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.225 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.47 44.74 3.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.31 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -115.2 155.35 27.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.614 0.245 . . . . 0.0 110.855 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 6.0 t -133.31 155.19 49.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.824 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.26 114.73 27.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.026 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 p -140.59 154.23 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.426 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.755 HD11 ' HA2' ' A' ' 20' ' ' GLY . 31.7 tp -84.01 128.99 34.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.55 160.58 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.595 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.31 -8.0 9.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.463 2.108 . . . . 0.0 112.541 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -97.7 -38.74 9.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.879 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.755 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 124.16 44.62 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.611 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.18 149.32 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 111.441 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.479 ' CE3' ' HB3' ' A' ' 1' ' ' HIS . 46.6 m95 -114.62 128.48 56.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.351 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -155.06 155.06 33.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.595 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -128.83 122.97 31.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.87 155.67 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.44 78.22 3.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.552 2.168 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -113.77 178.31 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.813 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 6.4 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.918 0.39 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.09 20.89 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.68 -10.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.34 12.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 41.3 m -143.8 -50.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 54.28 80.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.391 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 72.1 m -70.53 157.23 90.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.523 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HB2' HG21 ' A' ' 12' ' ' THR . 73.2 Cg_exo -48.68 162.2 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.518 2.145 . . . . 0.0 112.521 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.62 128.16 34.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.256 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.7 59.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.961 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.534 HG21 ' HB2' ' A' ' 9' ' ' PRO . 24.9 p -133.02 154.13 50.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.9 t -126.46 148.6 49.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.006 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.8 p -114.8 144.72 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.8 146.49 43.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.649 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.424 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 63.1 tp -78.37 137.23 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.5 156.81 38.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.22 -8.33 14.16 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.444 2.096 . . . . 0.0 112.293 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -98.43 -22.66 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.654 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.22 43.51 1.49 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.415 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.75 148.87 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.213 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 92.1 m95 -117.51 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 10.5 p90 -143.37 148.75 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -114.47 149.06 36.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.031 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 85.8 p -137.19 138.75 26.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 6.2 Cg_exo -78.75 20.41 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.02 2.48 . . . . 0.0 112.517 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -140.41 35.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.417 ' HA ' ' CG2' ' A' ' 13' ' ' THR . 3.0 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.825 0.345 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -160.67 114.64 2.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.5 42.86 26.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.87 -49.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -113.61 -61.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.6 mt 64.58 107.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.07 162.23 62.72 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.658 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.09 149.76 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.596 2.197 . . . . 0.0 112.562 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -62.86 135.61 57.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.88 9.68 85.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.645 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -126.61 150.36 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 0.0 111.242 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.1 t -120.06 152.34 37.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 p -114.72 126.61 55.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.3 147.78 42.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.808 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -82.03 116.26 21.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.94 156.97 86.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.693 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.91 -11.7 13.0 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.55 2.167 . . . . 0.0 112.207 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.23 -41.66 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.725 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.54 39.44 0.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.317 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.55 152.54 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 0.0 111.173 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.407 ' CE2' ' HG ' ' A' ' 16' ' ' LEU . 84.6 m95 -114.2 119.64 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 4.3 p90 -127.04 145.73 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -119.04 135.39 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.905 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.8 133.28 9.73 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.02 98.83 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.148 . . . . 0.0 112.564 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -135.66 179.99 6.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.924 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.422 ' HB2' ' H ' ' A' ' 7' ' ' ILE . 31.8 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.511 0.196 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.68 32.56 18.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.16 -19.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.58 -38.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.2 m -94.38 -63.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.422 ' H ' ' HB2' ' A' ' 2' ' ' CYS . 20.9 mt 64.78 124.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.571 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -74.95 152.0 86.52 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.93 136.85 22.8 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 61.88 -170.01 0.17 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.963 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 68.02 2.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.274 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 26' ' ' PRO . 69.6 p -130.9 155.65 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -114.2 152.68 30.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.568 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -114.55 147.04 40.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.113 0.482 . . . . 0.0 111.506 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.04 148.7 30.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.347 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.465 HD13 ' CE2' ' A' ' 22' ' ' TRP . 46.5 tp -93.0 109.1 20.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.222 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.31 162.29 73.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -61.62 -11.1 18.83 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.369 2.046 . . . . 0.0 112.351 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -92.72 5.7 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 68.67 50.4 36.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.454 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.88 150.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.35 . . . . 0.0 111.314 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.465 ' CE2' HD13 ' A' ' 16' ' ' LEU . 87.0 m95 -117.8 122.77 44.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.582 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.2 150.37 39.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -118.94 143.84 46.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.743 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -124.46 136.63 28.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.162 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.689 ' HA ' HG22 ' A' ' 12' ' ' THR . 10.3 Cg_exo -71.66 -18.85 28.53 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.902 2.401 . . . . 0.0 112.31 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 57.6 43.84 21.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.868 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 14' ' ' CYS . 69.3 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.841 0.353 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.66 178.27 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 54.4 -151.39 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.079 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.05 75.45 4.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.286 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -130.0 -72.59 0.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.073 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt 49.22 73.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.397 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.7 m -69.45 168.11 18.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.535 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HB2' HG23 ' A' ' 12' ' ' THR . 90.2 Cg_exo -44.98 152.78 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.445 2.097 . . . . 0.0 112.651 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -22.67 61.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.588 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' PRO . . . -102.39 19.21 49.05 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.729 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 27.9 p -137.28 155.42 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.36 . . . . 0.0 111.093 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.419 HG22 ' HZ ' ' A' ' 27' ' ' PHE . 10.8 t -115.51 156.42 25.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.356 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 12.0 m -113.67 127.96 56.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.4 m -142.6 141.6 32.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 62.4 tp -98.44 108.3 20.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.71 156.6 63.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.706 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.87 -17.13 22.53 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.54 2.16 . . . . 0.0 112.39 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -83.9 -33.88 24.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.71 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.442 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 114.44 44.83 0.7 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.319 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.81 152.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.022 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.2 m95 -114.81 128.53 56.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.527 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -129.0 150.46 50.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.225 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 84.8 m -144.15 120.27 10.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.793 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 t -131.13 144.39 53.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' GLY . 98.3 Cg_endo -79.9 133.37 10.12 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.573 2.182 . . . . 0.0 112.304 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.419 ' HZ ' HG22 ' A' ' 13' ' ' THR . 0.3 OUTLIER -101.15 99.47 9.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.986 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.805 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 24.3 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -153.34 108.24 3.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 57.48 37.38 27.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 -26.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 99.4 m -110.05 -53.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 mt 60.67 91.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -83.31 165.68 39.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.136 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.07 133.4 4.4 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.449 2.1 . . . . 0.0 112.365 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -50.48 119.98 4.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.4 10.59 50.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.617 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.488 HG22 ' CA ' ' A' ' 26' ' ' PRO . 6.9 p -129.31 150.24 50.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.299 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -119.95 143.43 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.76 146.35 41.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 111.351 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.49 137.09 15.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 57.5 tp -64.39 132.72 50.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 153.43 46.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.431 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.58 -14.88 18.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.084 . . . . 0.0 112.277 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -88.62 -32.02 18.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.69 46.31 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.854 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.22 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.448 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 87.1 m95 -116.44 124.24 49.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.174 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -149.59 144.72 26.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.458 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -117.61 132.79 56.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.629 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -117.44 136.99 23.7 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.227 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.488 ' CA ' HG22 ' A' ' 12' ' ' THR . 86.1 Cg_endo -81.75 2.14 8.75 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.377 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 61.44 -179.06 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.164 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.87 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.55 ' HA ' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.666 0.269 . . . . 0.0 111.006 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.86 5.85 41.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.007 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.44 -71.56 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.6 -57.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 8' ' ' CYS . 5.1 t 42.43 -159.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.973 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.465 ' N ' HG23 ' A' ' 6' ' ' THR . 4.8 pt -141.07 43.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 65.6 m -113.68 152.19 45.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.19 170.83 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.764 2.309 . . . . 0.0 112.788 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 118.36 12.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.4 30.18 28.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.74 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 63.0 p -130.45 154.69 47.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.064 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.1 t -121.08 155.41 34.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.7 p -114.22 134.92 54.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.937 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.86 147.55 31.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -84.73 138.2 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.424 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.66 158.79 32.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.73 -0.57 3.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.457 2.104 . . . . 0.0 112.649 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -104.06 -14.66 15.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.26 3.87 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.87 150.66 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 0.0 111.182 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CE2' ' HG ' ' A' ' 16' ' ' LEU . 87.3 m95 -114.88 141.6 47.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.49 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -152.96 153.58 33.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 13' ' ' THR . 4.6 m -114.79 119.17 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.93 141.38 41.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.33 31.96 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.695 2.264 . . . . 0.0 112.834 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -161.02 40.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 111.036 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.451 ' HA ' HG21 ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.891 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.961 0.41 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.63 107.44 16.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.184 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 50.66 -98.99 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.534 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.55 50.61 0.9 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 111.103 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.9 m -61.12 -48.25 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 7' ' ' ILE . 13.1 tt 35.08 87.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.628 0.58 . . . . 0.0 111.536 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -42.99 148.87 0.54 Allowed Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.329 -179.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.15 -173.11 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.663 2.242 . . . . 0.0 112.612 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 58.16 30.72 19.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.228 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.83 39.27 76.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.501 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 30.0 p -114.54 154.45 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.1 t -114.33 155.83 25.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.53 136.46 52.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.148 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.1 p -148.96 154.99 40.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.557 HD11 ' HA2' ' A' ' 20' ' ' GLY . 52.6 tp -82.58 141.42 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.38 152.86 41.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.65 -28.83 48.22 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.588 2.192 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.75 -25.05 23.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 113.62 55.16 0.42 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.401 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.15 141.09 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.248 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.479 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 77.8 m95 -114.9 123.24 48.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.573 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.44 153.12 39.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.945 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -114.84 134.05 55.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.099 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.62 143.74 22.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.848 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.63 89.28 1.17 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.638 2.225 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.77 32.88 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.983 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.984 0.421 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.44 167.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.98 -26.03 64.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.98 51.38 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.031 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.1 m -137.03 -78.04 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.08 59.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 3.3 m 59.98 165.78 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.531 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 Cg_endo -49.77 -72.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.585 2.19 . . . . 0.0 112.296 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -158.48 123.32 4.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.99 48.11 87.46 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.202 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.552 HG22 ' C ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -145.21 155.61 43.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 111.165 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.2 t -114.37 155.3 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.608 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -114.18 128.94 56.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.375 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.05 138.31 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.598 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 32.3 tp -84.3 125.42 32.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.24 156.96 68.82 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.733 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -36.52 15.22 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.73 2.287 . . . . 0.0 112.538 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -75.45 -81.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.766 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.39 36.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.58 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.91 147.53 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.8 m95 -114.64 122.91 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.212 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -114.36 155.49 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.999 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 13' ' ' THR . 37.7 m -114.36 116.71 29.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.502 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.552 ' C ' HG22 ' A' ' 12' ' ' THR . 0.1 OUTLIER -115.99 124.38 29.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.42 ' N ' HG22 ' A' ' 12' ' ' THR . 97.1 Cg_endo -81.01 91.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.57 2.18 . . . . 0.0 112.455 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -123.97 168.7 12.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.623 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.866 0.365 . . . . 0.0 110.9 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -13.32 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.87 -57.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.18 115.33 1.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.413 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.623 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 3.2 m -162.29 -39.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.024 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 mt 55.63 62.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.998 0.428 . . . . 0.0 110.649 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.521 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -57.37 161.98 4.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.253 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.52 139.24 44.26 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.796 2.331 . . . . 0.0 112.461 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.47 -162.79 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.0 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.49 63.46 4.43 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.521 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 72.6 p -114.92 155.22 27.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 1.2 m -121.61 153.06 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -113.88 121.96 45.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.951 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -122.24 148.93 44.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 22' ' ' TRP . 68.5 tp -97.11 113.01 24.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.068 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.45 157.48 72.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.363 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.57 -12.02 7.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.482 2.121 . . . . 0.0 112.453 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -88.75 -67.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.24 50.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.596 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.42 151.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 111.42 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 91.4 m95 -117.71 131.62 56.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 9.0 p90 -138.21 151.35 47.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.355 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' THR . 1.6 m -125.85 126.53 44.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.712 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.1 m -139.85 152.66 68.56 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -86.04 96.38 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.611 2.207 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -130.24 39.27 3.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.967 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.967 0.413 . . . . 0.0 111.102 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.5 161.53 29.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.79 -30.1 63.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 27.95 5.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -136.68 -95.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.433 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 5.5 mt 58.34 108.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-O 120.869 0.366 . . . . 0.0 111.682 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 m -59.24 120.26 46.16 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' CYS . 11.8 Cg_exo -70.69 -176.8 1.88 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.872 2.381 . . . . 0.0 112.633 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 55.5 -166.75 0.1 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.225 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.47 44.74 3.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.31 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -115.2 155.35 27.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.614 0.245 . . . . 0.0 110.855 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 6.0 t -133.31 155.19 49.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.824 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.26 114.73 27.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.026 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 p -140.59 154.23 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.426 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.755 HD11 ' HA2' ' A' ' 20' ' ' GLY . 31.7 tp -84.01 128.99 34.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.55 160.58 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.595 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.31 -8.0 9.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.463 2.108 . . . . 0.0 112.541 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -97.7 -38.74 9.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.879 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.755 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 124.16 44.62 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.611 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.18 149.32 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 111.441 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.475 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 46.6 m95 -114.62 128.48 56.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.351 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -155.06 155.06 33.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.595 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -128.83 122.97 31.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.87 155.67 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.44 78.22 3.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.552 2.168 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -113.77 178.31 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.813 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.794 0.33 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 6.4 p -103.11 57.46 0.76 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.09 20.89 4.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.68 -10.31 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.34 12.65 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 41.3 m -143.8 -50.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 54.28 80.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.391 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.529 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 72.1 m -70.53 157.23 90.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.523 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.534 ' HB2' HG21 ' A' ' 12' ' ' THR . 73.2 Cg_exo -48.68 162.2 0.39 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.518 2.145 . . . . 0.0 112.521 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.62 128.16 34.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.256 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.7 34.7 59.41 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.961 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.534 HG21 ' HB2' ' A' ' 9' ' ' PRO . 24.9 p -133.02 154.13 50.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 0.0 111.092 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.9 t -126.46 148.6 49.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.006 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.529 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.8 p -114.8 144.72 43.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.8 146.49 43.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.649 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.424 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 63.1 tp -78.37 137.23 37.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.5 156.81 38.15 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.22 -8.33 14.16 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.444 2.096 . . . . 0.0 112.293 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -98.43 -22.66 15.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.654 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 106.22 43.51 1.49 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.415 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.75 148.87 31.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 111.213 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.424 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 92.1 m95 -117.51 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 10.5 p90 -143.37 148.75 36.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -114.47 149.06 36.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.031 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 85.8 p -137.19 138.75 26.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.917 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 25' ' ' SER . 6.2 Cg_exo -78.75 20.41 0.79 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.02 2.48 . . . . 0.0 112.517 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -140.41 35.82 1.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.005 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.417 ' HA ' ' CG2' ' A' ' 13' ' ' THR . 3.0 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.297 -0.859 . . . . 0.0 111.112 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.746 0.308 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -92.21 90.28 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.981 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -160.67 114.64 2.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.5 42.86 26.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.14 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.87 -49.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.3 m -113.61 -61.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.6 mt 64.58 107.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.376 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.2 m -80.07 162.23 62.72 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.658 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.09 149.76 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.596 2.197 . . . . 0.0 112.562 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -62.86 135.61 57.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.108 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.88 9.68 85.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.645 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -126.61 150.36 48.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.785 0.326 . . . . 0.0 111.242 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.1 t -120.06 152.34 37.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 7.3 p -114.72 126.61 55.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.144 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -117.3 147.78 42.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.808 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HG ' ' CE2' ' A' ' 22' ' ' TRP . 0.7 OUTLIER -82.03 116.26 21.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.94 156.97 86.01 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.693 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.91 -11.7 13.0 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.55 2.167 . . . . 0.0 112.207 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.23 -41.66 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.725 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.54 39.44 0.47 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.317 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.55 152.54 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.829 0.347 . . . . 0.0 111.173 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.407 ' CE2' ' HG ' ' A' ' 16' ' ' LEU . 84.6 m95 -114.2 119.64 37.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.506 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 4.3 p90 -127.04 145.73 50.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.934 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -119.04 135.39 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.905 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.8 133.28 9.73 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -80.02 98.83 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.523 2.148 . . . . 0.0 112.564 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -135.66 179.99 6.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.801 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.924 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.856 0.36 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.422 ' HB2' ' H ' ' A' ' 7' ' ' ILE . 31.8 p -117.37 -162.04 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.78 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.68 32.56 18.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.703 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.16 -19.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.672 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.58 -38.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.2 m -94.38 -63.94 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.707 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.422 ' H ' ' HB2' ' A' ' 2' ' ' CYS . 20.9 mt 64.78 124.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.571 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -74.95 152.0 86.52 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.468 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -47.93 136.85 22.8 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 61.88 -170.01 0.17 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.963 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.36 68.02 2.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.274 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.689 HG22 ' HA ' ' A' ' 26' ' ' PRO . 69.6 p -130.9 155.65 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -114.2 152.68 30.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.568 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 p -114.55 147.04 40.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.113 0.482 . . . . 0.0 111.506 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.04 148.7 30.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.347 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.465 HD13 ' CE2' ' A' ' 22' ' ' TRP . 46.5 tp -93.0 109.1 20.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.9 0.381 . . . . 0.0 111.222 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.31 162.29 73.54 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.289 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -61.62 -11.1 18.83 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.369 2.046 . . . . 0.0 112.351 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -92.72 5.7 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.063 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.446 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 68.67 50.4 36.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.454 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.88 150.86 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.35 . . . . 0.0 111.314 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.465 ' CE2' HD13 ' A' ' 16' ' ' LEU . 87.0 m95 -117.8 122.77 44.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.582 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.2 150.37 39.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.113 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -118.94 143.84 46.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.743 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.4 OUTLIER -124.46 136.63 28.02 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.162 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.689 ' HA ' HG22 ' A' ' 12' ' ' THR . 10.3 Cg_exo -71.66 -18.85 28.53 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.902 2.401 . . . . 0.0 112.31 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 57.6 43.84 21.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.008 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.868 179.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.425 ' HE1' ' HA ' ' A' ' 15' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.953 0.406 . . . . 0.0 111.157 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.554 ' HA ' ' HB2' ' A' ' 14' ' ' CYS . 69.3 m -60.44 100.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.113 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.66 178.27 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.692 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 54.4 -151.39 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.079 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.05 75.45 4.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.286 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.5 m -130.0 -72.59 0.57 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.073 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 mt 49.22 73.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.397 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.7 m -69.45 168.11 18.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.535 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HB2' HG23 ' A' ' 12' ' ' THR . 90.2 Cg_exo -44.98 152.78 0.49 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.445 2.097 . . . . 0.0 112.651 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -22.67 61.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.588 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' PRO . . . -102.39 19.21 49.05 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.729 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 27.9 p -137.28 155.42 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.36 . . . . 0.0 111.093 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.419 HG22 ' HZ ' ' A' ' 27' ' ' PHE . 10.8 t -115.51 156.42 25.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.356 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 12.0 m -113.67 127.96 56.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.425 ' HA ' ' HE1' ' A' ' 1' ' ' HIS . 2.4 m -142.6 141.6 32.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 62.4 tp -98.44 108.3 20.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.71 156.6 63.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.706 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.87 -17.13 22.53 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.54 2.16 . . . . 0.0 112.39 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -83.9 -33.88 24.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.71 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.442 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 114.44 44.83 0.7 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.319 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.81 152.44 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.022 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.2 m95 -114.81 128.53 56.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.527 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -129.0 150.46 50.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.225 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 84.8 m -144.15 120.27 10.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.793 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 t -131.13 144.39 53.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' GLY . 98.3 Cg_endo -79.9 133.37 10.12 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.573 2.182 . . . . 0.0 112.304 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.419 ' HZ ' HG22 ' A' ' 13' ' ' THR . 0.3 OUTLIER -101.15 99.47 9.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.986 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.805 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.61 ' HB2' ' HZ3' ' A' ' 22' ' ' TRP . 7.3 p80 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.664 0.269 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 24.3 p -57.25 108.32 0.52 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -153.34 108.24 3.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 57.48 37.38 27.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 -26.61 0.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.123 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 99.4 m -110.05 -53.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 mt 60.67 91.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.125 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -83.31 165.68 39.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.136 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -42.07 133.4 4.4 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.449 2.1 . . . . 0.0 112.365 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -50.48 119.98 4.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.331 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 98.4 10.59 50.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.617 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.488 HG22 ' CA ' ' A' ' 26' ' ' PRO . 6.9 p -129.31 150.24 50.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.299 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 5.8 t -119.95 143.43 48.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.76 146.35 41.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.001 0.429 . . . . 0.0 111.351 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.49 137.09 15.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.657 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 57.5 tp -64.39 132.72 50.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.155 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.31 153.43 46.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.431 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.58 -14.88 18.22 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.084 . . . . 0.0 112.277 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -88.62 -32.02 18.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.69 46.31 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.854 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.1 150.22 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.92 0.39 . . . . 0.0 111.37 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.61 ' HZ3' ' HB2' ' A' ' 1' ' ' HIS . 87.1 m95 -116.44 124.24 49.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.174 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -149.59 144.72 26.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.458 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -117.61 132.79 56.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.629 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 m -117.44 136.99 23.7 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.227 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.488 ' CA ' HG22 ' A' ' 12' ' ' THR . 86.1 Cg_endo -81.75 2.14 8.75 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.759 2.306 . . . . 0.0 112.377 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 61.44 -179.06 0.12 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.164 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.87 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.796 0.332 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.55 ' HA ' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -156.49 4.85 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.006 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.86 5.85 41.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.007 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.44 -71.56 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.6 -57.73 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.918 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.552 HG23 ' H ' ' A' ' 8' ' ' CYS . 5.1 t 42.43 -159.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.973 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.465 ' N ' HG23 ' A' ' 6' ' ' THR . 4.8 pt -141.07 43.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.948 0.404 . . . . 0.0 111.207 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 65.6 m -113.68 152.19 45.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.96 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.19 170.83 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.764 2.309 . . . . 0.0 112.788 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.12 118.36 12.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.172 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.4 30.18 28.28 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.74 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 63.0 p -130.45 154.69 47.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 111.064 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.1 t -121.08 155.41 34.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.629 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.7 p -114.22 134.92 54.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.937 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.86 147.55 31.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.757 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -84.73 138.2 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.948 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.424 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -97.66 158.79 32.42 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.594 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.73 -0.57 3.22 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.457 2.104 . . . . 0.0 112.649 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -104.06 -14.66 15.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.26 3.87 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.87 150.66 34.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.839 0.352 . . . . 0.0 111.182 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.416 ' CE2' ' HG ' ' A' ' 16' ' ' LEU . 87.3 m95 -114.88 141.6 47.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.49 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -152.96 153.58 33.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.83 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 13' ' ' THR . 4.6 m -114.79 119.17 35.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.93 141.38 41.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.33 31.96 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.695 2.264 . . . . 0.0 112.834 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -161.02 40.88 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 111.036 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.451 ' HA ' HG21 ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.143 -0.932 . . . . 0.0 110.891 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.612 0.244 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.2 m -52.37 101.37 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.923 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.63 107.44 16.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.184 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 50.66 -98.99 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.534 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.55 50.61 0.9 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 111.103 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.9 m -61.12 -48.25 82.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 7' ' ' ILE . 13.1 tt 35.08 87.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 123.628 0.58 . . . . 0.0 111.536 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.1 OUTLIER -42.99 148.87 0.54 Allowed Pre-proline 0 C--N 1.332 -0.174 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.329 -179.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -74.15 -173.11 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.663 2.242 . . . . 0.0 112.612 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.0 t0 58.16 30.72 19.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.228 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.83 39.27 76.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.501 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 30.0 p -114.54 154.45 28.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 0.0 110.9 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 2.1 t -114.33 155.83 25.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.111 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.5 p -113.53 136.46 52.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.148 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.1 p -148.96 154.99 40.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.557 HD11 ' HA2' ' A' ' 20' ' ' GLY . 52.6 tp -82.58 141.42 32.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.38 152.86 41.39 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.743 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.65 -28.83 48.22 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.588 2.192 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.75 -25.05 23.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 113.62 55.16 0.42 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.401 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 68.1 t -134.15 141.09 44.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.831 0.348 . . . . 0.0 111.248 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.479 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 77.8 m95 -114.9 123.24 48.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.573 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -147.44 153.12 39.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.945 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -114.84 134.05 55.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.099 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.62 143.74 22.48 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.848 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -82.63 89.28 1.17 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.638 2.225 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -109.77 32.88 4.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.983 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.628 0.252 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.1 m -51.61 104.39 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.969 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.44 167.57 1.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.975 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.98 -26.03 64.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.14 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.98 51.38 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.031 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.1 m -137.03 -78.04 0.4 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.071 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 mm 54.08 59.83 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.535 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 3.3 m 59.98 165.78 0.09 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.531 ' HD2' ' SG ' ' A' ' 24' ' ' CYS . 6.5 Cg_endo -49.77 -72.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.585 2.19 . . . . 0.0 112.296 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -158.48 123.32 4.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 58.99 48.11 87.46 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.202 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.552 HG22 ' C ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -145.21 155.61 43.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.79 0.329 . . . . 0.0 111.165 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 10.2 t -114.37 155.3 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.608 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -114.18 128.94 56.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.934 0.397 . . . . 0.0 111.375 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.05 138.31 50.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.598 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HB2' ' CH2' ' A' ' 22' ' ' TRP . 32.3 tp -84.3 125.42 32.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.154 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.24 156.96 68.82 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.733 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -45.82 -36.52 15.22 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.73 2.287 . . . . 0.0 112.538 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -75.45 -81.88 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.766 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.39 36.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.58 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.6 t -115.91 147.53 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' A' ' 16' ' ' LEU . 89.8 m95 -114.64 122.91 47.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.212 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -114.36 155.49 26.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.999 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 13' ' ' THR . 37.7 m -114.36 116.71 29.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.502 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.552 ' C ' HG22 ' A' ' 12' ' ' THR . 0.1 OUTLIER -115.99 124.38 29.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.42 ' N ' HG22 ' A' ' 12' ' ' THR . 97.1 Cg_endo -81.01 91.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.57 2.18 . . . . 0.0 112.455 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -123.97 168.7 12.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.951 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.844 0.354 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.623 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -154.91 -157.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.9 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -13.32 37.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.33 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.87 -57.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.055 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.18 115.33 1.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.413 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.623 ' HB ' ' HB2' ' A' ' 2' ' ' CYS . 3.2 m -162.29 -39.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.024 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.5 mt 55.63 62.15 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.998 0.428 . . . . 0.0 110.649 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.521 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.8 OUTLIER -57.37 161.98 4.97 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.253 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.52 139.24 44.26 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.796 2.331 . . . . 0.0 112.461 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.47 -162.79 0.13 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.0 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.49 63.46 4.43 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.406 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.521 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 72.6 p -114.92 155.22 27.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 111.027 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 1.2 m -121.61 153.06 38.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -113.88 121.96 45.55 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.914 0.388 . . . . 0.0 110.951 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.9 m -122.24 148.93 44.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.642 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.477 ' HB2' ' CZ2' ' A' ' 22' ' ' TRP . 68.5 tp -97.11 113.01 24.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.068 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.45 157.48 72.0 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.363 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.57 -12.02 7.75 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.482 2.121 . . . . 0.0 112.453 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -88.75 -67.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 155.24 50.47 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.596 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.42 151.02 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.79 0.329 . . . . 0.0 111.42 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.477 ' CZ2' ' HB2' ' A' ' 16' ' ' LEU . 91.4 m95 -117.71 131.62 56.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 14' ' ' CYS . 9.0 p90 -138.21 151.35 47.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.823 0.344 . . . . 0.0 111.355 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' THR . 1.6 m -125.85 126.53 44.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.712 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.1 m -139.85 152.66 68.56 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.059 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -86.04 96.38 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.611 2.207 . . . . 0.0 112.481 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -130.24 39.27 3.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.967 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.479 ' HB3' ' CE3' ' A' ' 22' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.614 0.245 . . . . 0.0 111.15 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -48.2 96.39 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.102 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.5 161.53 29.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.97 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.79 -30.1 63.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.218 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.43 27.95 5.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.002 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.0 m -136.68 -95.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.433 ' HA ' ' HB3' ' A' ' 2' ' ' CYS . 5.5 mt 58.34 108.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-O 120.869 0.366 . . . . 0.0 111.682 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 m -59.24 120.26 46.16 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.808 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' CYS . 11.8 Cg_exo -70.69 -176.8 1.88 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.872 2.381 . . . . 0.0 112.633 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 55.5 -166.75 0.1 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.225 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.47 44.74 3.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.31 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 8' ' ' CYS . 13.5 p -115.2 155.35 27.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.614 0.245 . . . . 0.0 110.855 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 6.0 t -133.31 155.19 49.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.813 0.34 . . . . 0.0 111.824 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.26 114.73 27.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.026 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.3 p -140.59 154.23 46.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.426 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.755 HD11 ' HA2' ' A' ' 20' ' ' GLY . 31.7 tp -84.01 128.99 34.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.122 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.55 160.58 61.47 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.595 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.31 -8.0 9.56 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.463 2.108 . . . . 0.0 112.541 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -97.7 -38.74 9.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.879 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.755 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . 124.16 44.62 0.29 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.611 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.18 149.32 27.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.808 0.337 . . . . 0.0 111.441 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.479 ' CE3' ' HB3' ' A' ' 1' ' ' HIS . 46.6 m95 -114.62 128.48 56.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.351 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -155.06 155.06 33.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.862 0.363 . . . . 0.0 111.595 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -128.83 122.97 31.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.817 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.87 155.67 48.91 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.44 78.22 3.57 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.552 2.168 . . . . 0.0 112.438 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -113.77 178.31 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.813 -179.964 . . . . . . . . 0 0 . 1 stop_ save_